http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4025633-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4e7207cc25af4b83e566d886fc6fa0e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-092 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-084 |
filingDate | 1975-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1977-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2a631f881c8f9d26231f806732583f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32fab7e2e474490034bcfaede64f7781 |
publicationDate | 1977-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4025633-A |
titleOfInvention | α,α-Diaryl-β-(tert-amino)-propanols and pharmaceutical compositions containing them |
abstract | α,α-Diaryl-β-(tert-amino)-propanols having the general formula: ##STR1## wherein R', R" and R 1 to R 10 represent certain specific substituent groups, exhibit a diuretic and saluretic activity. n Pharmaceutical composition containing at least one compound of the general Formula II together with a pharmaceutically acceptable diluent or carrier. The pharmaceutical compositions may be in a form suitable for oral or parenteral administration. |
priorityDate | 1974-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.